MADRIGAL PHARMACEUTICALS, INC.

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $280,000.00 expenses · posted Jan 22, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to CMMI drug pricing

Health Issues

Most Favored Nation drug pricing; Issues related to CMMI drug pricing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.